Comments
Loading...
Capricor Therapeutics (CAPR) Forecast
NewsEarningsCapricor Therapeutics (CAPR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCapricor Therapeutics (NASDAQ:CAPR) Stock Quotes, Forecast and News Summary
Capricor Therapeutics Stock (NASDAQ: CAPR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Capricor Therapeutics (CAPR) stock?
You can purchase shares of Capricor Therapeutics (NASDAQ:CAPR) through any online brokerage.
Who are Capricor Therapeutics (CAPR) competitors?
Other companies in Capricor Therapeutics’s space includes: Immunome (NASDAQ:IMNM), Tectonic Therapeutic (NASDAQ:TECX), Gyre Therapeutics (NASDAQ:GYRE), Valneva (NASDAQ:VALN) and Precigen (NASDAQ:PGEN).
What is the forecast, or price target, for Capricor Therapeutics (CAPR) stock?
Capricor Therapeutics has a consensus price target of $39.29.
What is the current price for Capricor Therapeutics (CAPR)?
The stock price for Capricor Therapeutics (NASDAQ: CAPR) is $15.29 last updated February 21, 2025 at 9:12 AM EST.
Does Capricor Therapeutics (CAPR) pay a dividend?
There are no upcoming dividends for Capricor Therapeutics.
When is Capricor Therapeutics (NASDAQ:CAPR) reporting earnings?
Capricor Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Capricor Therapeutics (CAPR) going to split?
There is no upcoming split for Capricor Therapeutics.
What sector and industry does Capricor Therapeutics (CAPR) operate in?
Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.